With the rapid development of modern biomedicine, there is a growing demand for animal models in drug discovery and development. In the field of humanized mouse models, MHC (major histocompatibility complex) humanized mouse models have become a research hotspot due to their high simulation of the human immune system. As a leading developer of MHC humanized mouse models in China, InnoModels Biotechnology provides efficient and accurate experimental animal models for global drug discovery and development.
MHC humanized mouse model is to introduce human MHC gene into mouse genome through genetic engineering technology, so that mice can mimic the human immune system and produce similar immune responses to foreign drugs and antigens. This model has important application value in drug screening, disease mechanism research, vaccine development and other fields.
Since its establishment, InnoModels Biotechnology has been focusing on the research and application of MHC humanized mouse models. The company has a strong team of senior scientists, technical experts and R&D team with rich experience in the research and development of MHC humanized mouse models. The company has successfully developed a variety of MHC humanized mouse models, and can be customized according to the needs of customers to meet the needs of different experimental animal models in the process of drug discovery and development.

With the corporate philosophy of "Innovation, Quality, Service", we provide one-stop service from model design, R&D, production to sales. The company has passed ISO9001 quality management system certification to ensure that we can provide customers with high quality products and services. In addition, the company has also established strategic cooperative relationships with many well-known pharmaceutical companies and research institutes at home and abroad to jointly promote the development of drug research and development.
In the future development, InnoModels Biotechnology will continue to increase the investment in R&D and devote itself to the innovation and breakthrough of MHC humanized mouse model technology, so as to provide more and better experimental animal models for the global drug discovery and development field. At the same time, the company will also join hands with its partners to jointly promote China's drug R&D to a higher level and help the development of human health.
In conclusion, as a leader in MHC humanized mouse models, InnoModels Biotechnology, with its strong R&D strength, high quality products and services, brings infinite possibilities to the global drug discovery field. In the near future, InnoModels Biotechnology is expected to become the world's leading company in the development and application of MHC humanized mouse models, and make greater contributions to the cause of human health.